ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 82 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $669 | -99.9% | 1,803,858 | 0.0% | 0.04% | -2.6% |
| Q3 2022 | $902,000 | -14.4% | 1,803,858 | 0.0% | 0.04% | -32.1% |
| Q2 2022 | $1,054,000 | -17.9% | 1,803,858 | 0.0% | 0.06% | +3.7% |
| Q1 2022 | $1,284,000 | -46.1% | 1,803,858 | 0.0% | 0.05% | -16.9% |
| Q4 2021 | $2,381,000 | -42.6% | 1,803,858 | 0.0% | 0.06% | -30.1% |
| Q3 2021 | $4,149,000 | -47.6% | 1,803,858 | 0.0% | 0.09% | -42.2% |
| Q2 2021 | $7,919,000 | -39.5% | 1,803,858 | 0.0% | 0.16% | -30.3% |
| Q1 2021 | $13,096,000 | +762.7% | 1,803,858 | +413.2% | 0.23% | +600.0% |
| Q4 2020 | $1,518,000 | +5.1% | 351,500 | 0.0% | 0.03% | -5.7% |
| Q3 2020 | $1,445,000 | -34.9% | 351,500 | -5.0% | 0.04% | -43.5% |
| Q2 2020 | $2,220,000 | -26.3% | 370,000 | -7.5% | 0.06% | -51.2% |
| Q1 2020 | $3,012,000 | -37.4% | 400,000 | +14.3% | 0.13% | -31.7% |
| Q4 2019 | $4,813,000 | +15.8% | 350,000 | 0.0% | 0.19% | +11.4% |
| Q3 2019 | $4,158,000 | -15.1% | 350,000 | 0.0% | 0.17% | -15.7% |
| Q2 2019 | $4,897,000 | – | 350,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 6,449,856 | $8,514,000 | 2.83% |
| RA Capital Management | 9,694,789 | $12,797,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $9,173,000 | 0.19% |
| HARBOR CAPITAL ADVISORS, INC. | 275,870 | $364,000 | 0.13% |
| Artal Group S.A. | 1,803,858 | $2,381,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 338,756 | $447,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,335,174 | $1,762,000 | 0.05% |
| PVG ASSET MANAGEMENT CORP | 10,000 | $13,200,000 | 0.05% |
| Anson Funds Management LP | 348,266 | $460,000 | 0.04% |
| Eversept Partners, LP | 419,581 | $553,847 | 0.04% |